Cargando...
Pharmacologic Therapies for Idiopathic Pulmonary Fibrosis, Past and Future
Idiopathic pulmonary fibrosis (IPF) is a severe, progressive fibrotic disease of the lung of unknown etiology that affects approximately 150,000 patients in the United States. It carries a median survival of two to three years, but clinical course can vary markedly from patient to patient. There has...
Gardado en:
| Publicado en: | Ann Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4638420/ https://ncbi.nlm.nih.gov/pubmed/25613169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07853890.2014.991751 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|